John Sloane

CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

R Powles, H.M. Clink, David J. Spence et al. · The Lancet · 1980 · 416 citations

Life Sciences, Immunology, Pharmacotherapy +10

MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA

R Powles, H. E. M. Kay, H.M. Clink et al. · The Lancet · 1983 · 268 citations

Medicine, Genetics, Hematology +10

CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN

R Powles, H.M. Clink, John Sloane et al. · The Lancet · 1978 · 212 citations

Life Sciences, Immunology, Immunopathology +11

Nature of the toxicity of cyclosporin A in the rat

Michael J.G. Farthing, Michael Clark, Ann Pendry et al. · Biochemical Pharmacology · 1981 · 104 citations

Pharmacy, Pharmacology, Toxicology +10

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

Helmout Modjtahedi, Tamas Hickish, Margery Nicolson et al. · British Journal of Cancer · 1996 · 102 citations · Full text

Medicine, Oncology, Molecular Oncology +12